{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T19:39:25Z","timestamp":1777577965801,"version":"3.51.4"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Symbiosis International"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"DOI":"10.1007\/s00404-026-08368-5","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T19:32:43Z","timestamp":1777404763000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparing oxytocin alternatives for postpartum hemorrhage prevention in vaginal and caesarean births: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"313","author":[{"given":"Seeta","family":"Devi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maneesha Rajendrakumar","family":"Suryavanshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramesh","family":"Chandrababu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"key":"8368_CR1","volume-title":"StatPearls","author":"KC Wormer","year":"2023","unstructured":"Wormer KC, Jamil RT, Bryant SB (2023) Acute postpartum hemorrhage. StatPearls. StatPearls Publishing, Treasure Island (FL)"},{"key":"8368_CR2","volume-title":"A roadmap to combat postpartum haemorrhage between 2023 and 2030","author":"World Health Organization","year":"2023","unstructured":"World Health Organization (2023) A roadmap to combat postpartum haemorrhage between 2023 and 2030. World Health Organization, Geneva"},{"issue":"7","key":"8368_CR3","first-page":"442","volume":"95","author":"A Evensen","year":"2017","unstructured":"Evensen A, Anderson JM, Fontaine P (2017) Postpartum hemorrhage: prevention and treatment. Am Fam Physician 95(7):442\u2013449","journal-title":"Am Fam Physician"},{"key":"8368_CR4","doi-asserted-by":"publisher","DOI":"10.1177\/23333928211062777","volume":"8","author":"T Amanuel","year":"2021","unstructured":"Amanuel T, Dache A, Dona A (2021) Postpartum hemorrhage and its associated factors among women who gave birth at Yirgalem General Hospital, Sidama Regional State, Ethiopia. Health Serv Res Manag Epidemiol 8:23333928211062777. https:\/\/doi.org\/10.1177\/23333928211062777","journal-title":"Health Serv Res Manag Epidemiol"},{"issue":"5","key":"8368_CR5","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1097\/AOG.0000000000001405","volume":"127","author":"American College of Obstetricians and Gynecologists","year":"2016","unstructured":"American College of Obstetricians and Gynecologists (2016) Practice bulletin No. 162. Obstet Gynecol 127(5):108\u2013122","journal-title":"Obstet Gynecol"},{"issue":"9","key":"8368_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta23090","volume":"23","author":"I Gallos","year":"2019","unstructured":"Gallos I, Williams H, Price M et al (2019) Uterotonic drugs to prevent postpartum haemorrhage: a network meta-analysis. Health Technol Assess 23(9):1\u2013356. https:\/\/doi.org\/10.3310\/hta23090","journal-title":"Health Technol Assess"},{"key":"8368_CR7","volume-title":"WHO recommendations for the prevention and treatment of postpartum haemorrhage","author":"World Health Organization","year":"2012","unstructured":"World Health Organization (2012) WHO recommendations for the prevention and treatment of postpartum haemorrhage. World Health Organization, Geneva"},{"key":"8368_CR8","volume-title":"WHO recommendations: uterotonics for the prevention of postpartum haemorrhage","author":"World Health Organization","year":"2018","unstructured":"World Health Organization (2018) WHO recommendations: uterotonics for the prevention of postpartum haemorrhage. World Health Organization, Geneva"},{"issue":"8","key":"8368_CR9","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1056\/NEJMoa1805489","volume":"379","author":"M Widmer","year":"2018","unstructured":"Widmer M, Piaggio G, Nguyen TMH et al (2018) Heat-stable carbetocin versus oxytocin to prevent hemorrhage after vaginal birth. N Engl J Med 379(8):743\u2013752. https:\/\/doi.org\/10.1056\/NEJMoa1805489","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"8368_CR10","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.25259\/IJMA_4_2024","volume":"13","author":"D Ruto","year":"2024","unstructured":"Ruto D, Muthamia M, Njeri E et al (2024) Introduction of heat-stable carbetocin for postpartum hemorrhage prevention in public sector hospitals in Kenya: provider experience and policy insights. Int J MCH AIDS 13(Suppl 1):S28-37. https:\/\/doi.org\/10.25259\/IJMA_4_2024","journal-title":"Int J MCH AIDS"},{"issue":"10084","key":"8368_CR11","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1016\/S0140-6736(17)30638-4","volume":"389","author":"WOMAN Trial Collaborators","year":"2017","unstructured":"WOMAN Trial Collaborators (2017) Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with postpartum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet 389(10084):2105\u20132116. https:\/\/doi.org\/10.1016\/S0140-6736(17)30638-4","journal-title":"Lancet"},{"issue":"10463","key":"8368_CR12","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1016\/S0140-6736(24)01749-5","volume":"404","author":"WOMAN-2 Trial Collaborators","year":"2024","unstructured":"WOMAN-2 Trial Collaborators (2024) The effect of tranexamic acid on postpartum bleeding in women with moderate and severe anaemia (WOMAN-2): an international, randomised, double-blind, placebo-controlled trial. Lancet 404(10463):1645\u20131656. https:\/\/doi.org\/10.1016\/S0140-6736(24)01749-5","journal-title":"Lancet"},{"issue":"1","key":"8368_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-018-3081-x","volume":"19","author":"K Ker","year":"2018","unstructured":"Ker K, Roberts I, Chaudhri R et al (2018) Tranexamic acid for the prevention of postpartum bleeding in women with anaemia: study protocol for an international, randomised, double-blind, placebo-controlled trial. Trials 19(1):712. https:\/\/doi.org\/10.1186\/s13063-018-3081-x","journal-title":"Trials"},{"key":"8368_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/ijgo.14116","volume":"157","author":"MF Escobar","year":"2022","unstructured":"Escobar MF, Nassar AH, Theron G et al (2022) FIGO recommendations on the management of postpartum hemorrhage 2022. Int J Gynaecol Obstet 157:3\u201350","journal-title":"Int J Gynaecol Obstet"},{"key":"8368_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"8368_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/9781119536604","volume-title":"Cochrane handbook for systematic reviews of interventions","author":"JPT Higgins","year":"2019","unstructured":"Higgins JPT, Thomas J, Chandler J et al (2019) Cochrane handbook for systematic reviews of interventions. Cochrane"},{"key":"8368_CR17","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jclinepi.2016.01.021","volume":"75","author":"J McGowan","year":"2016","unstructured":"McGowan J, Sampson M, Salzwedel DM et al (2016) PRESS peer review of electronic search strategies: 2015 guideline statement. J Clin Epidemiol 75:40\u201346","journal-title":"J Clin Epidemiol"},{"key":"8368_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898. https:\/\/doi.org\/10.1136\/bmj.l4898","journal-title":"BMJ"},{"issue":"7109","key":"8368_CR19","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Smith GD, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629\u2013634","journal-title":"BMJ"},{"issue":"3","key":"8368_CR20","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/ijgo.14743","volume":"162","author":"D Korb","year":"2023","unstructured":"Korb D, Lopez R, H\u00f6rlin AL et al (2023) Effectiveness of prophylactic carbetocin versus oxytocin following vaginal delivery for preventing severe postpartum hemorrhage. Int J Gynaecol Obstet 162(3):889\u2013894","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"8368_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-023-09263-4","volume":"23","author":"JR Cook","year":"2023","unstructured":"Cook JR, Saxena K, Taylor C et al (2023) Cost-effectiveness and budget impact of heat-stable carbetocin compared to oxytocin and misoprostol for the prevention of postpartum hemorrhage in women giving birth in India. BMC Health Serv Res 23(1):267","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"8368_CR22","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/ijgo.14938","volume":"164","author":"R Ghosh","year":"2024","unstructured":"Ghosh R, Owa O, Santos N et al (2024) Heat stable carbetocin or oxytocin for prevention of postpartum hemorrhage among women at risk: a secondary analysis of the CHAMPION trial. Int J Gynaecol Obstet 164(1):124\u2013130","journal-title":"Int J Gynaecol Obstet"},{"issue":"3","key":"8368_CR23","doi-asserted-by":"publisher","first-page":"279","DOI":"10.5468\/ogs.23128","volume":"67","author":"AA Sambo","year":"2024","unstructured":"Sambo AA, Nwachukwu D, Nwosu IC et al (2024) A randomized controlled study comparing oral misoprostol with intramuscular oxytocin in active management of third stage of labour. Obstet Gynecol Sci 67(3):279\u2013285","journal-title":"Obstet Gynecol Sci"},{"key":"8368_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102665","author":"A Ragusa","year":"2024","unstructured":"Ragusa A, Ficarola F, Ferrari A et al (2024) Tranexamic acid versus oxytocin prophylaxis in reducing post-partum blood loss, in low-risk pregnant women: TRANOXY STUDY, a phase III randomized clinical trial. EClinicalMedicine. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102665","journal-title":"EClinicalMedicine"},{"issue":"4","key":"8368_CR25","first-page":"334","volume":"4","author":"LK Mahato","year":"2022","unstructured":"Mahato LK, Nayak S, Devashish K et al (2022) Methods for comparing the effectiveness of misoprostol with oxytocin against oxytocin alone in avoiding postpartum bleeding. Int J Acad Med Pharm 4(4):334\u2013337","journal-title":"Int J Acad Med Pharm"},{"issue":"2","key":"8368_CR26","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1097\/FM9.0000000000000048","volume":"2","author":"H Liu","year":"2020","unstructured":"Liu H, Xu XY, Gu N et al (2020) Intravenous administration of carbetocin versus oxytocin for preventing postpartum hemorrhage after vaginal delivery in high-risk women: a double-blind, randomized controlled trial. Matern Fetal Med 2(2):72\u201379","journal-title":"Matern Fetal Med"},{"issue":"8","key":"8368_CR27","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1056\/NEJMoa1800942","volume":"379","author":"L Sentilhes","year":"2018","unstructured":"Sentilhes L, Winer N, Azria E et al (2018) Tranexamic acid for the prevention of blood loss after vaginal delivery. N Engl J Med 379(8):731\u2013742","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"8368_CR28","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1007\/s13224-016-0856-4","volume":"66","author":"P Roy","year":"2016","unstructured":"Roy P, Sujatha MS, Bhandiwad A, Biswas B (2016) Role of tranexamic acid in reducing blood loss in vaginal delivery. J Obstet Gynaecol India 66(Suppl 1):246\u2013250","journal-title":"J Obstet Gynaecol India"},{"key":"8368_CR29","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s13224-016-0842-x","volume":"66","author":"KS Sunil Kumar","year":"2016","unstructured":"Sunil Kumar KS, Shyam S, Batakurki P (2016) Carboprost versus oxytocin for active management of third stage of labor: a prospective randomized control study. J Obstet Gynaecol India 66:229\u2013234","journal-title":"J Obstet Gynaecol India"},{"issue":"1","key":"8368_CR30","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1016\/S2214-109X(15)00219-3","volume":"4","author":"A Diop","year":"2016","unstructured":"Diop A, Daff B, Sow M, Blum J, Diagne M, Sloan NL, Winikoff B (2016) Oxytocin via Uniject (a prefilled single-use injection) versus oral misoprostol for prevention of postpartum haemorrhage at the community level: a cluster-randomised controlled trial. Lancet Glob Health 4(1):e37\u2013e44","journal-title":"Lancet Glob Health"},{"issue":"1","key":"8368_CR31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3329\/bjog.v30i1.30499","volume":"30","author":"N Kabir","year":"2015","unstructured":"Kabir N, Akter D, Daisy TA, Jesmin S, Razzak M, Tasnim S, Islam GR (2015) Efficacy and safety of carbetocin in comparison to oxytocin in the active management of third stage of labour following vaginal delivery: an open label randomized control trial. Bangladesh J Obstet Gynaecol 30(1):3\u20139","journal-title":"Bangladesh J Obstet Gynaecol"},{"issue":"4","key":"8368_CR32","doi-asserted-by":"publisher","first-page":"147","DOI":"10.4103\/fjs.fjs_122_22","volume":"55","author":"S Singh","year":"2022","unstructured":"Singh S, Mishra R, Singh A, Shaifulla P (2022) Comparative study of oxytocin versus tranexamic acid and ethamsylate in preventing primary postpartum hemorrhage in women undergoing lower-segment cesarean section. Formosan J Surg 55(4):147\u2013153","journal-title":"Formosan J Surg"},{"issue":"9","key":"8368_CR33","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1111\/1471-0528.17445","volume":"130","author":"SH Lee","year":"2023","unstructured":"Lee SH, Kwek MEJ, Tagore S et al (2023) Tranexamic acid, as an adjunct to oxytocin prophylaxis, in the prevention of postpartum haemorrhage in women undergoing elective caesarean section: a single\u2010centre double\u2010blind randomised controlled trial. BJOG 130(9):1007\u20131015","journal-title":"BJOG"},{"issue":"3","key":"8368_CR34","first-page":"203","volume":"31","author":"AG Bangash","year":"2023","unstructured":"Bangash AG, Riaz S, Akhtar Z, Naz T, Naib JM (2023) Tranexamic acid plus oxytocin prophylaxis in reducing blood loss and preventing postpartum hemorrhage during cesarean section. J Med Sci 31(3):203\u2013207","journal-title":"J Med Sci"},{"issue":"1","key":"8368_CR35","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.21608\/ejhm.2024.363736","volume":"96","author":"M Abdelgalil","year":"2024","unstructured":"Abdelgalil M, Elmarasy E, Taher A, Elmazny A, Elzyat A (2024) Carbetocin versus oxytocin for prevention of postpartum hemorrhage in twin pregnancies delivered by cesarean section: a randomized controlled trial. Egypt J Hosp Med 96(1):2410\u20132416","journal-title":"Egypt J Hosp Med"},{"issue":"4","key":"8368_CR36","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/01.aoa.0000891656.66489.88","volume":"42","author":"A Tareef","year":"2022","unstructured":"Tareef A, Downey K, Ma B, Whittle W, Carvalho J (2022) Carbetocin versus oxytocin following vaginal and cesarean delivery: a before-after study. Obstet Anesth Dig 42(4):187\u2013189","journal-title":"Obstet Anesth Dig"},{"issue":"1","key":"8368_CR37","doi-asserted-by":"publisher","DOI":"10.31083\/j.ceog4901023","volume":"49","author":"S Kang","year":"2022","unstructured":"Kang S, Zhou L, Zhu L et al (2022) Carbetocin versus oxytocin for the prevention of postpartum hemorrhage after elective caesarean section in high-risk women: a prospective, randomized, open-label, controlled trial in China. Clin Exp Obstet Gynecol 49(1):23","journal-title":"Clin Exp Obstet Gynecol"},{"issue":"1","key":"8368_CR38","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1186\/s12884-023-05935-5","volume":"23","author":"M Dawoud","year":"2023","unstructured":"Dawoud M, Al-Husseiny M, Helal O et al (2023) Intravenous tranexamic acid vs. sublingual misoprostol in high-risk women for postpartum haemorrhage following cesarean delivery; a randomised clinical trial. BMC Pregnancy Childbirth 23(1):611","journal-title":"BMC Pregnancy Childbirth"},{"key":"8368_CR39","doi-asserted-by":"publisher","DOI":"10.21608\/aimj.2021.61234.1439","author":"A Mohamed","year":"2021","unstructured":"Mohamed A, Farhan A, AlSheikh A (2021) Comparative study between oxytocin versus tranexamic acid and ethamsylate to reduce blood loss intra-operative and postoperative during elective cesarean section. Al-Azhar Int Med. https:\/\/doi.org\/10.21608\/aimj.2021.61234.1439","journal-title":"Al-Azhar Int Med"},{"key":"8368_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007872.pub3","author":"N Novikova","year":"2015","unstructured":"Novikova N, Hofmeyr GJ, Cluver C (2015) Tranexamic acid for preventing postpartum haemorrhage. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD007872.pub3","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"8368_CR41","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005653","volume":"96","author":"C Li","year":"2017","unstructured":"Li C, Gong Y, Dong L, Xie B, Dai Z (2017) Is prophylactic tranexamic acid administration effective and safe for postpartum hemorrhage prevention? A systematic review and meta-analysis. Medicine (Baltimore) 96(1):e5653","journal-title":"Medicine (Baltimore)"},{"key":"8368_CR42","volume":"2022","author":"X Huang","year":"2022","unstructured":"Huang X, Xue W, Zhou J, Zhou C, Yang F (2022) Effect of carbetocin on postpartum hemorrhage after vaginal delivery: a meta\u2010analysis. Comput Math Methods Med 2022:6420738","journal-title":"Comput Math Methods Med"},{"issue":"19","key":"8368_CR43","doi-asserted-by":"publisher","first-page":"3368","DOI":"10.1080\/14767058.2019.1571576","volume":"33","author":"G Saccone","year":"2020","unstructured":"Saccone G, Della Corte L, D\u2019Alessandro P et al (2020) Prophylactic use of tranexamic acid after vaginal delivery reduces the risk of primary postpartum hemorrhage. J Matern Fetal Neonatal Med 33(19):3368\u20133376","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"5","key":"8368_CR44","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1080\/14767058.2018.1500544","volume":"33","author":"L Della Corte","year":"2018","unstructured":"Della Corte L, Saccone G, Locci M et al (2018) Tranexamic acid for treatment of primary postpartum hemorrhage after vaginal delivery: a systematic review and meta-analysis of randomized controlled trials. J Matern Fetal Neonatal Med 33(5):869\u2013874","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"4","key":"8368_CR45","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.ajog.2021.09.025","volume":"226","author":"I Bellos","year":"2022","unstructured":"Bellos I, Pergialiotis V (2022) Tranexamic acid for the prevention of postpartum hemorrhage in women undergoing cesarean delivery: an updated meta-analysis. Am J Obstet Gynecol 226(4):510\u201323.e22","journal-title":"Am J Obstet Gynecol"},{"key":"8368_CR46","doi-asserted-by":"publisher","DOI":"10.24200\/jogcr.10.10.789","author":"J Judio","year":"2025","unstructured":"Judio J, Nathalia J, Christiany C, Cicilia I (2025) Carbetocin vs oxytocin for prevention of postpartum hemorrhage in cesarean delivery: a systematic review and meta-analysis. J Obstet Gynecol Cancer Res. https:\/\/doi.org\/10.24200\/jogcr.10.10.789","journal-title":"J Obstet Gynecol Cancer Res"},{"issue":"1","key":"8368_CR47","doi-asserted-by":"publisher","DOI":"10.1111\/jog.16194","volume":"51","author":"AM Maged","year":"2025","unstructured":"Maged AM, El-Goly NA, Turki D, Bassiouny N, El-Demiry N (2025) A systematic review and meta-analysis of randomized trials comparing carbetocin to oxytocin in prevention of postpartum hemorrhage after cesarean delivery in low-risk women. J Obstet Gynaecol Res 51(1):e16194. https:\/\/doi.org\/10.1111\/jog.16194","journal-title":"J Obstet Gynaecol Res"},{"key":"8368_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-023-06100-8","volume":"23","author":"NM Al-Dardery","year":"2023","unstructured":"Al-Dardery NM, Abdelwahab OA, Abouzid M et al (2023) Efficacy and safety of tranexamic acid in prevention of postpartum hemorrhage: a systematic review and meta-analysis of 18,649 patients. BMC Pregnancy Childbirth 23:817. https:\/\/doi.org\/10.1186\/s12884-023-06100-8","journal-title":"BMC Pregnancy Childbirth"},{"issue":"14","key":"8368_CR49","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1080\/14767058.2019.1664463","volume":"34","author":"E Kalafat","year":"2021","unstructured":"Kalafat E, Gokce A, O\u2019Brien P et al (2021) Efficacy of carbetocin in the prevention of postpartum hemorrhage: a systematic review and Bayesian meta-analysis of randomized trials. J Matern Fetal Neonatal Med 34(14):2303\u20132316","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"4","key":"8368_CR50","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/jebm.12201","volume":"9","author":"J Tan","year":"2016","unstructured":"Tan J, Cao Q, He GL et al (2016) Misoprostol versus ergometrine\u2010oxytocin for preventing postpartum haemorrhage: a systematic review and meta\u2010analysis of randomized controlled trials. J Evid Based Med 9(4):194\u2013204","journal-title":"J Evid Based Med"},{"issue":"1","key":"8368_CR51","doi-asserted-by":"publisher","first-page":"40.e1","DOI":"10.1016\/j.ajog.2013.03.015","volume":"209","author":"A Conde-Agudelo","year":"2013","unstructured":"Conde-Agudelo A, Nieto A, Rosas-Bermudez A, Romero R (2013) Misoprostol to reduce intraoperative and postoperative hemorrhage during cesarean delivery: a systematic review and meta-analysis. Am J Obstet Gynecol 209(1):40.e1","journal-title":"Am J Obstet Gynecol"},{"key":"8368_CR52","doi-asserted-by":"publisher","DOI":"10.2471\/B09571","volume-title":"Consolidated guidelines for the prevention, diagnosis and treatment of postpartum haemorrhage","author":"World Health Organization","year":"2025","unstructured":"World Health Organization (2025) Consolidated guidelines for the prevention, diagnosis and treatment of postpartum haemorrhage. World Health Organization, Geneva"},{"issue":"Suppl 1","key":"8368_CR53","first-page":"S35","volume":"119","author":"S Raghavan","year":"2012","unstructured":"Raghavan S, Abbas D, Winikoff B (2012) Misoprostol for prevention and treatment of postpartum hemorrhage: what do we know? What is next? Int J Gynaecol Obstet 119(Suppl 1):S35\u2013S38","journal-title":"Int J Gynaecol Obstet"},{"key":"8368_CR54","volume":"7","author":"GJ Hofmeyr","year":"2013","unstructured":"Hofmeyr GJ, G\u00fclmezoglu AM, Novikova N, Lawrie TA (2013) Postpartum misoprostol for preventing maternal mortality and morbidity. Cochrane Database Syst Rev 7:CD008982","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-026-08368-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-026-08368-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-026-08368-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T19:32:45Z","timestamp":1777404765000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-026-08368-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8368"],"URL":"https:\/\/doi.org\/10.1007\/s00404-026-08368-5","relation":{},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"assertion":[{"value":"24 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable, as this is a review study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"178"}}